This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Cornell University, Tri-Institutional Therapeutics Discovery Institute. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2021-2024
Title: Ayumu Sato: Innovator in Pharmaceutical Compounds
Introduction
Ayumu Sato is a notable inventor based in Zushi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. With a total of 2 patents, Sato's work is recognized for its potential impact on treatment methodologies.
Latest Patents
Sato's latest patents include innovative compounds such as pyridinone- and pyridazinone-based compounds. These compounds are designed for the treatment of fibrotic diseases, abnormal vascular leak, and pathological angiogenesis. Another significant patent involves inhibitors of soluble adenylyl cyclase, which are specific compounds that can reduce cyclic AMP levels and are useful in treating conditions like ocular hypotony.
Career Highlights
Throughout his career, Ayumu Sato has worked with prestigious institutions such as Cornell University and the Tri-Institutional Therapeutics Discovery Institute. His research has focused on developing pharmaceutical compounds that can lead to improved health outcomes.
Collaborations
Sato has collaborated with notable colleagues, including Timothy Hla and Irina Jilishitz. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Ayumu Sato's innovative work in pharmaceutical compounds showcases his dedication to improving medical treatments. His contributions are paving the way for new therapeutic options in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile